HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.

Abstract
The antiemetic effects of a novel serotonin3 receptor antagonist, DAT-582 [(6R)-(-)-N-[1-methyl-4-(3-methylbenzyl)hexahydro-1H-1,4- diazepin-6-yl]-1H-indazole-3-carboxamide dihydrochloride] were compared with those of the existing serotonin3 receptor antagonists, ondansetron and granisetron, in experimental animals. In ferrets, DAT-582 (0.003-0.1 mg/kg i.v. twice) dose-relatedly prolonged the latency to the first emetic episode and decreased the number of emetic episodes induced by cisplatin (10 mg/kg i.v.). DAT-582 was more potent than ondansetron or granisetron in inhibiting the emesis. The emesis induced by cyclophosphamide (150 mg/kg i.v.), doxorubicin (15 mg/kg i.v.) or combination of cisplatin (3.3 mg/kg i.v.), cyclophosphamide (50 mg/kg i.v.) and doxorubicin (5 mg/kg i.v.) was also inhibited by DAT-582 (0.1 mg/kg i.v., twice). When administered 2 hr before cisplatin in ferrets, DAT-582 decreased markedly the number of emetic episodes induced by cisplatin at 0.1 mg/kg i.v., whereas ondansetron and granisetron were without effect even at 0.3 mg/kg i.v. DAT-582 (0.1 mg/kg i.v.), when administered in the ferrets which were vomiting after cisplatin, immediately and almost completely blocked the subsequent emesis. Furthermore, DAT-582 (0.1 mg/kg i.v.) completely inhibited the cisplatin (3 mg/kg i.v.)-induced emesis for 24 hr after cisplatin in three of five dogs. In addition, DAT-582, at 0.3 and 1 mg/kg, p.o., inhibited the cisplatin-induced emesis in dogs. However, DAT-582, even at 3 mg/kg s.c., did not inhibit the apomorphine (0.3 mg/kg,, s.c.)-induced emesis in dogs, or the nicotine-, copper sulfate- or motion stimulus-induced emesis in the house musk shrew, Suncus Murinus.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsN Yoshida, H Omoya, T Ito
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 260 Issue 3 Pg. 1159-65 (Mar 1992) ISSN: 0022-3565 [Print] United States
PMID1532032 (Publication Type: Journal Article)
Chemical References
  • Antiemetics
  • Azepines
  • Imidazoles
  • Indazoles
  • Receptors, Serotonin
  • Serotonin Antagonists
  • DAT 582
  • Ondansetron
  • Nicotine
  • Copper
  • Copper Sulfate
  • Cisplatin
Topics
  • Animals
  • Antiemetics (pharmacology)
  • Azepines (pharmacology)
  • Cisplatin (toxicity)
  • Copper (toxicity)
  • Copper Sulfate
  • Dogs
  • Female
  • Ferrets
  • Gastric Emptying (drug effects)
  • Imidazoles (pharmacology)
  • Indazoles (pharmacology)
  • Male
  • Nicotine (toxicity)
  • Ondansetron
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin (drug effects)
  • Serotonin Antagonists (pharmacology)
  • Shrews

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: